SCHEMBL2122693

SCHEMBL2122693

C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC(CC(=O)OC5CC(=O)C=C6CC[C@@H]7[C@H]([C@@H](O)C[C@@]8(C)[C@H]7CC[C@]8(O)C(=O)CO)[C@]65C)[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 12/20 0.62
▸ HSD17B10 Q99714 6/20 0.62
▸ CYP2C19 P33261 4/20 0.62
▸ NR3C1 P04150 4/20 0.62
▸ SERPINA6 P08185 4/20 0.62
▸ PGR P06401 4/20 0.62
▸ CYP3A4 P08684 4/20 0.62
▸ NR3C2 P08235 4/20 0.62
▸ SMN1; SMN2 Q16637 4/20 0.62
▸ KMT2A Q03164 2/20 0.62
▸ NFKB1 P19838 2/20 0.62
▸ MAPT P10636 2/20 0.62
▸ SHBG P04278 2/20 0.62
▸ AR P10275 2/20 0.57
▸ ABCB11 O95342 1/20 0.57
▸ TNF P01375 1/20 0.57
▸ IL6 P05231 1/20 0.57
▸ GLUL P15104 1/20 0.57
▸ ADAM17 P78536 1/20 0.57
▸ GPBAR1 Q8TDU6 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28340921 0.94 HIF1A (0.62) HIF1AHSD17B10CYP2C19NR3C1SERPINA6
SCHEMBL28809123 0.93 HIF1A (0.66) HIF1AHSD17B10CYP2C19NR3C1SERPINA6
SCHEMBL19463057 0.93 HSD17B10 (0.56) HIF1AHSD17B10CYP2C19NR3C1SERPINA6
SCHEMBL6001323 0.93 HIF1A (0.65) HIF1AHSD17B10CYP2C19NR3C1SERPINA6
SCHEMBL249836 0.92 HIF1A (0.64) HIF1AHSD17B10CYP2C19NR3C1SERPINA6
SCHEMBL14931695 0.92 HIF1A (0.64) HIF1AHSD17B10CYP2C19NR3C1SERPINA6
SCHEMBL180226 0.92 HIF1A (0.64) HIF1AHSD17B10CYP2C19NR3C1SERPINA6
SCHEMBL11238419 0.91 HIF1A (0.63) HIF1AHSD17B10CYP2C19NR3C1SERPINA6
SCHEMBL27698464 0.91 HIF1A (0.63) HIF1AHSD17B10CYP2C19NR3C1SERPINA6
SCHEMBL1535104 0.91 HIF1A (0.63) HIF1AHSD17B10CYP2C19NR3C1SERPINA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150299366-A1 MOLECULARLY IMPRINTED POLYMER NANOPARTICLES COMPATIBLE WITH BIOLOGICAL SAMPLES AND PREPARATION METHOD THEREOF NANKAI UNIVERSITY (CN) 2015-10-22 — — US claimed
CN-116761893-A Method for transducing immune cells 艾洛基治疗公司 2023-09-15 — — CN disclosed
CN-107920973-B Surface modification composition 株式会社LG生活健康 2021-05-07 — — CN disclosed
EP-2442771-B1 SILICONE SCAR TREATMENT PREPARATION ADVANCED BIO TECH INC (US) 2020-02-05 — — EP disclosed
US-10053531-B2 Molecularly imprinted polymer nanoparticles compatible with biological samples and preparation method thereof NANKAI UNIVERSITY (CN) 2018-08-21 — — US disclosed
US-9795706-B2 Silicone scar treatment preparation ADVANCED BIO-TECHNOLOGIES, INC. (US) 2017-10-24 — — US disclosed
US-20160213810-A1 SILICONE SCAR TREATMENT PREPARATION ADVANCED BIO-TECHNOLOGIES, INC. 2016-07-28 — — US disclosed
CN-105813578-A Formulations and methods for increasing or reducing mucus 弗赛特影像5股份有限公司 2016-07-27 — — CN disclosed
CN-105792868-A Apparatus and methods for low-volume medicament delivery 豪夫迈·罗氏有限公司 2016-07-20 — — CN disclosed
US-9339546-B2 Silicone scar treatment preparation ADVANCED BIO-TECHNOLOGIES, INC. (US) 2016-05-17 — — US disclosed
US-20140314695-A1 SILICONE SCAR TREATMENT PREPARATION ADVANCED BIO-TECHNOLOGIES, INC. 2014-10-23 — — US disclosed
US-8802133-B2 Silicone scar treatment preparation ADVANCED BIO-TECHNOLOGIES, INC. (US) 2014-08-12 — — US disclosed
US-20130183256-A1 SILICONE SCAR TREATMENT PREPARATION ADVANCED BIO-TECHNOLOGIES, INC. (US) 2013-07-18 — — US disclosed
EP-2442771-A1 SILICONE SCAR TREATMENT PREPARATION Advanced Bio-Technologies, Inc. (US) 2012-04-25 — — EP disclosed
US-20100322875-A1 SILICONE SCAR TREATMENT PREPARATION ADVANCED BIO-TECHNOLOGIES, INC. (US) 2010-12-23 — — US disclosed
WO-2010148310-A1 SILICONE SCAR TREATMENT PREPARATION ADVANCED BIO-TECHNOLOGIES, INC. (US) 2010-12-23 — — WO disclosed
CN-1250562-C Process for preparing hydrocortisone acetate SHANDONG XINHUA PHARMACEUTICAL (CN) 2006-04-12 — — CN disclosed
CN-1603333-A Process for preparing hydrocortisone acetate SHANDONG XINHUA PHARMACEUTICAL (CN) 2005-04-06 — — CN disclosed
WO-2001010907-A9 THERAPEUTIC POLYPEPTIDES AND METHODS FOR USING SAME UNIV MARYLAND BIOTECH INST (US) 2002-07-11 — — WO disclosed
US-4252719-A REMOVAL OF A TERTIARY HYDROGEN FROM A 5-A-STEROID BY CHLORINATING THE STEROID BEING FIRST ESTERIFIED BY AN IODOARYL-CONTAINING ESTERIFICATION AGENT RESEARCH CORPORATION (US) 1981-02-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130183256-A1 SILICONE SCAR TREATMENT PREPARATION MMP1, COL1A1, COL2A1 HIF1A 1964/4885HSD17B10 174/4885CYP2C19 2952/4885
US-20100322875-A1 SILICONE SCAR TREATMENT PREPARATION MMP1, COL1A1, COL2A1 HIF1A 1964/4885HSD17B10 174/4885CYP2C19 2952/4885
US-20160213810-A1 SILICONE SCAR TREATMENT PREPARATION MMP1, COL1A1, COL2A1 HIF1A 1964/4885HSD17B10 174/4885CYP2C19 2952/4885
US-20140314695-A1 SILICONE SCAR TREATMENT PREPARATION MMP1, COL1A1, COL2A1 HIF1A 1964/4885HSD17B10 174/4885CYP2C19 2952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback